For example, low antigen expression, low MHC expression or other antigen processing and presenting molecule alteration, and insensitivity to the pro-apoptotic signals from T cells would all lead to a disconnect between the results of an immune monitoring assay in peripheral blood and tumor responses [15]. This evidence concerns the gene HLA-C and neoplasm.